UCLA Broad Stem Cell

BSCRC member Dr. Yvonne Chen talks to @foxnewsnight about how personalized CAR-T cell therapies are offering hope and results for cancer patients today. #ResearchPowersProgress foxnews.com/video/63998759…

UCLA's Broad Stem Cell Research Center brings stem cell science to more than 400 LA area high schoolers this spring, using everything from Pokémon evolution to LeBron James to make the research click. newsroom.ucla.edu/releases/ucla-…

Lentiviral vectors for hematopoietic stem cell gene therapy restore α-globin expression in α-thalassemia red blood cells. Research by Donald B. Kohn (@UCLAstemcell) & colleagues in @CellRepMed #ISSCR2026 hubs.li/Q04nPwDg0

UCLA’s Dr. Amy Vandiver received a $700K @BWFUND award to study the biological drivers of human aging. “Aging is the biggest risk factor for many of the diseases we treat. We now need to move this knowledge towards actionable interventions.” Read more: ow.ly/pfzX50ZmbSL

Congratulations to Dr. Amy Vandiver on receiving the @BWFUND Career Award for Medical Scientists! The award supports outstanding early-career physician-scientists as they establish independent academic research careers. bit.ly/3Taz8Bz

Meet Yvonne Chen, PhD, who designs CAR-T therapies to make cancer treatment safer and more effective. She talks leading a lymphoma clinical trial, meeting a patient who benefitted from her work and how karaoke connects her to her grandparents. 🔗 bit.ly/4aI3WzH

UCLA is the birthplace of the Internet. And @UCLA researchers helped develop Herceptin, saving lives and transforming breast cancer treatment for patients around the world. The summer issue of UCLA Magazine celebrates that spirit of inquiry. ucla.in/4gJQD5N

“Their entire shell is sort of made of calcium carbonate, & they’re really stiff,” said algae expert @BraybrookSA, who sought to identify the varied species of articulated coralline algae. "They almost look like coral, that’s why we call them corallines.” kpbs.org/news/environme…

From Pokémon to LeBron James, young researchers at @UCLA are stepping into L.A. classrooms and using pop culture references high school students already know to make cutting-edge science click. ➡️ bit.ly/4aGvvJL

ICYMI: UCLA's Lili Yang has received a $7.49M @cirmnews grant to develop an off-the-shelf CAR-NKT cell therapy for #MultipleSclerosis. While current treatments manage symptoms over time, this approach is designed to target the disease at its source. ow.ly/luVo50ZhmOr

My PhD thesis work is published!! Our clonal studies of HSCs and T cell progenitors demonstrated comparable T cell potential in young and aged cells in vitro. If you’re interested in stem cells, the thymus, and/or aging research, take a look! dx.doi.org/10.1111/acel.7…

Abstracts for the iPSC 20th Anniversary Symposium are due 29 July! Join us in Kyoto, Japan, to celebrate the 20th anniversary of the discovery of induced pluripotent stem cells. Share your findings, exchange ideas, & grow your network 👉 bit.ly/3LfeufB

Grant from the DoD will help researchers develop a new approach that combines engineered nanovial technology with single-cell analysis to rapidly evaluate & optimize dual-targeted CAR T-cell therapies for metastatic castration-resistant prostate cancer. bit.ly/4v0QbmW

Have you had a chance to visit Microscopic Marvels yet? The exhibit provides a visual journey showcasing the extraordinary science happening right here at the BSCRC. We hope to see you there! On display on level 2 of Powell Library, in the Rotunda and Main Reading Room.

A $7.49 million grant from @cirmnews will help a team of @UCLA researchers led by Lili Yang develop a universal CAR-NKT cell immunotherapy for multiple sclerosis, a chronic autoimmune disease that affects nearly one million adults in the U.S. ow.ly/r7lG50ZhmxT

UCLA's Dino Di Carlo is leading the Billion CellxCell Project to map how human cells communicate and unlock new disease therapies. newsroom.ucla.edu/releases/can-s…

Meet @UCLA's Steven Jonas, the doctor building tiny tools for big science breakthroughs: ow.ly/NWe650ZgGqt #ResearchPowersProgress

A UCLA team led by @dinodicarlo is launching the Billion Cell×Cell Project — an effort to generate 1 billion measurements of controlled interactions between pairs of human cells. The goal: understand how cells communicate in health and disease. Read more: ow.ly/5Cbn50ZfUAt

Introducing UCLA’s new FDA-compliant cGMP facility: the Center for Advanced Biotherapies (CAB). From cancer vaccines to stem cell gene therapies, CAB accelerates promising treatments into first-in-human clinical trials. Read more: ucla.in/4eqiciM

Mark your calendars for a special 90-minute Technology Spotlight I3T Seminar on Monday, June 22nd at 11:30am in room CHS 23-105. Lunch will be provided. For more information email I3T@mednet.ucla.edu or visit: medschool.ucla.edu/immunology